Successful 6-Week Antibiotic Treatment for Early Surgical-site Infections in Spinal Surgery
- 20 September 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 68 (11) , 1856-1861
Abstract
The incidence of spinal surgical site infections (SSI) remains stable at less than 10%. Surgical reinterventions may be hampered by decubitus, treatment-related adverse events, and cost. In the context of emergence of bacterial resistance, a short duration of antimicrobial treatment is of critical importance. If the duration of treatment for SSI is currently 12 weeks, the aim of our study was to assess the efficacy of an antimicrobial treatment shortened to six weeks. This prospective study was carried out from November 2014 to July 2016 in an 827-bed teaching hospital. After surgical management of SSI, patients received broad-spectrum antibiotics, intravenously for 10 days and orally for the remainder, for a total of six weeks. Success was defined as absence of relapse, superinfection or surgical failure at the end of treatment and at one-year follow-up. Eighty-five patients were included in this study. The median delay between initial surgery and diagnosis of SSI was 16 days. In 65 cases (76·4 %) SSIs were monomicrobial and among these, Staphylococcus aureus was found in 30 cases (46 %). Failure was observed in 7 cases (8·2%), with over half of them caused by anaerobic bacteria. Surgical management of SSI followed by a 6-week antibiotic treatment is associated with favourable outcome. Anaerobic bacteria seem to play a role in the occurrence of relapses. A 6-week reduction in antibiotic treatment leads to reduction in cost and, likely, also to reduction in the emergence and spread of resistant microorganisms.Keywords
This publication has 25 references indexed in Scilit:
- Reduction of surgical site infection in spine surgery: an opportunity for quality improvement and cost reductionThe Spine Journal, 2013
- Infection risk for primary and revision instrumented lumbar spine fusion in the Medicare populationJournal of Neurosurgery: Spine, 2012
- An Analysis of Causes of Readmission After Spine SurgerySpine, 2012
- Postoperative Infection Treatment Score for the Spine (PITSS): construction and validation of a predictive model to define need for single versus multiple irrigation and debridement for spinal surgical site infectionThe Spine Journal, 2012
- Infections in spinal instrumentationInternational Orthopaedics, 2012
- Rates of Infection After Spine Surgery Based on 108,419 ProceduresSpine, 2011
- Postoperative Instrumented Spine Infections: A Retrospective ReviewSouthern Medical Journal, 2010
- Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009
- The Management and Outcome of Spinal Implant Infections: Contemporary Retrospective Cohort StudyClinical Infectious Diseases, 2007
- Risk Factors for Surgical Site Infection in the Patient With Spinal InjurySpine, 2003